PriceTargets.com logo

MediPharm Labs - LABS Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.07 As of 02/24/2026 04:59 PM ET
▼ -0.005 (-7.14%)

This chart shows the closing price for LABS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MediPharm Labs Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LABS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LABS

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for MediPharm Labs in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$0.07.

This chart shows the closing price for LABS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in MediPharm Labs. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/2/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/1/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2026

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/4/2022Canaccord Genuity GroupLower TargetC$0.35 ➝ C$0.20
4/4/2022Alliance Global PartnersLower TargetBuyC$0.35 ➝ C$0.25
11/16/2021Alliance Global PartnersDowngradeHoldC$0.35
8/17/2021Alliance Global PartnersLower TargetStrong-BuyC$1.00 ➝ C$0.80
5/19/2021Alliance Global PartnersLower TargetC$1.25 ➝ C$1.00
5/19/2021ATB Cormark Capital MarketsLower TargetC$0.60 ➝ C$0.50
5/18/2021Alliance Global PartnersBoost TargetStrong-BuyC$1.00 ➝ C$1.25
5/18/2021ATB Cormark Capital MarketsBoost TargetSector PerformC$0.50 ➝ C$0.60
4/1/2021Alliance Global PartnersLower TargetStrong-BuyC$2.00 ➝ C$1.25
(Data available from 2/24/2021 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2026

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
MediPharm Labs logo
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Read More

Today's Range

Now: C$0.07
Low: C$0.07
High: C$0.07

50 Day Range

MA: C$0.07
Low: C$0.07
High: C$0.08

52 Week Range

Now: C$0.07
Low: C$0.06
High: C$0.12

Volume

93,036 shs

Average Volume

144,702 shs

Market Capitalization

C$27.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of MediPharm Labs?

The following sell-side analysts have issued stock ratings on MediPharm Labs in the last twelve months:
View the latest analyst ratings for LABS.

What is the current price target for MediPharm Labs?

0 Wall Street analysts have set twelve-month price targets for MediPharm Labs in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for MediPharm Labs in the next year.
View the latest price targets for LABS.

What is the current consensus analyst rating for MediPharm Labs?

MediPharm Labs currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for LABS.

What other companies compete with MediPharm Labs?

Other companies that are similar to MediPharm Labs include Medexus Pharmaceuticals, Green Organic Dutchman, Delta 9 Cannabis, WeedMD and Decibel Cannabis. Learn More about companies similar to MediPharm Labs.

How do I contact MediPharm Labs' investor relations team?

MediPharm Labs' physical mailing address is 151 John Street, Barrie, ON L4N 2L1, Canada. The company's listed phone number is 705 719 7425. The official website for MediPharm Labs is www.medipharmlabs.com. Learn More about contacing MediPharm Labs investor relations.